AVG-002

N/A

Report date: 2024/03/21 15:48:10

Base Information

Drug NameAVG-002
Drug Alias NameAVG-002
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Lentiviral vector
Mechanisms of ActionPulmonary surfactant-associated protein B gene transference
TargetsPulmonary surfactant-associated protein B
Therapy Area/IndicationsRespiratory Distress Syndrome, Newborn
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlveoGene Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAlveoGene Ltd
Inactive CompaniesN/A
Active IndicationsRespiratory Distress Syndrome, Newborn
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A